Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Monsanto buys Israeli crop bioengineering firm
Monsanto agreed to pay $35 million to purchase the assets of Rosetta Green, a crop bioengineering company based in Israel. The spinoff from Rosetta Genomics develops traits and identifies genes useful for farming and fuel applications.
Or we can send an email on your behalf